RIHAWI, KARIM
 Distribuzione geografica
Continente #
NA - Nord America 413
EU - Europa 217
AS - Asia 121
SA - Sud America 7
AF - Africa 5
OC - Oceania 2
Totale 765
Nazione #
US - Stati Uniti d'America 406
CN - Cina 61
IT - Italia 51
DE - Germania 35
FR - Francia 31
IE - Irlanda 24
BG - Bulgaria 20
ES - Italia 20
TR - Turchia 12
IN - India 11
JP - Giappone 11
AE - Emirati Arabi Uniti 8
GB - Regno Unito 8
CA - Canada 7
KR - Corea 6
ID - Indonesia 5
NL - Olanda 5
CZ - Repubblica Ceca 4
FI - Finlandia 4
MK - Macedonia 4
AR - Argentina 3
EG - Egitto 3
GR - Grecia 3
HK - Hong Kong 3
AU - Australia 2
CL - Cile 2
PE - Perù 2
DK - Danimarca 1
IQ - Iraq 1
LV - Lettonia 1
NG - Nigeria 1
PH - Filippine 1
PK - Pakistan 1
RO - Romania 1
RS - Serbia 1
RU - Federazione Russa 1
SE - Svezia 1
SI - Slovenia 1
TW - Taiwan 1
UA - Ucraina 1
ZA - Sudafrica 1
Totale 765
Città #
Ashburn 44
Houston 37
Santa Cruz 30
Dublin 24
Beijing 23
Buffalo 22
Sofia 19
Fairfield 18
Madrid 18
Woodbridge 17
Seattle 15
Ann Arbor 11
Chicago 11
Bologna 10
Los Angeles 10
Cambridge 9
Frankfurt am Main 8
Wilmington 8
Boardman 7
Bremen 6
Kunming 6
Las Vegas 6
New York 6
Ankara 5
Guangzhou 5
Paris 5
Southend 5
Atlanta 4
Mountain View 4
Riva 4
Seongbuk-gu 4
Toronto 4
Washington 4
Brookline 3
Buenos Aires 3
Cairo 3
Chengdu 3
Cleveland 3
Forlì 3
Hangzhou 3
Helsinki 3
Lyon 3
Milpitas 3
Osaka 3
Phoenix 3
Rome 3
San Diego 3
Shanghai 3
Skopje 3
Xian 3
Baltimore 2
Broadview Heights 2
Cankaya 2
Dallas 2
Deil 2
Delhi 2
Fleming Island 2
Groningen 2
Henderson 2
Istanbul 2
Kolkata 2
Koto 2
Munich 2
Murcia 2
Ottawa 2
Padova 2
Parma 2
Partinico 2
Piura 2
Rimini 2
San Francisco 2
San Prisco 2
Tokyo 2
Ujjain 2
Vercelli 2
Abano Terme 1
Adana 1
Athens 1
Auburn 1
Avellino 1
Bangalore 1
Belgrade 1
Bengaluru 1
Bethesda 1
Borca 1
Boulder 1
Bunbury 1
Burgas 1
Bursa 1
Central District 1
Cesena 1
Clearwater 1
Council Bluffs 1
Crugers 1
Cuneo 1
Dalian 1
Dongguan 1
Erbil 1
Eurasburg 1
Faenza 1
Totale 535
Nome #
Emerging therapies in malignant pleural mesothelioma, file e1dcb336-e1ae-7715-e053-1705fe0a6cc9 176
Pembrolizumab in the treatment of metastatic non-small cell lung cancer: A review of current evidence, file e1dcb335-794d-7715-e053-1705fe0a6cc9 131
A streamlined workflow for single-cells genome-wide copy-number profiling by low-pass sequencing of LM-PCR whole-genome amplification products., file e1dcb332-de99-7715-e053-1705fe0a6cc9 121
MYC Amplification as a Potential Mechanism of Primary Resistance to Crizotinib in ALK-Rearranged Non-Small Cell Lung Cancer: A Brief Report, file e1dcb335-0258-7715-e053-1705fe0a6cc9 109
Reliability of programmed death ligand 1 (PD-L1) tumor proportion score (TPS) on cytological smears in advanced non-small cell lung cancer: a prospective validation study, file e1dcb337-8831-7715-e053-1705fe0a6cc9 64
Automated Prediction of the Response to Neoadjuvant Chemoradiotherapy in Patients Affected by Rectal Cancer, file cf9f18b6-6c42-410c-b713-49eccd71bf27 51
The autocrine loop of ALK receptor and ALKAL2 ligand is an actionable target in consensus molecular subtype 1 colon cancer, file daf66676-7c72-4ae8-aad0-62753fad4fdb 36
Novel HER2-directed treatments in advanced gastric carcinoma: Another paradigm shift?, file e1dcb339-308f-7715-e053-1705fe0a6cc9 27
Tumor-associated macrophages and inflammatory microenvironment in gastric cancer: Novel translational implications, file e1dcb338-c511-7715-e053-1705fe0a6cc9 26
Roles of IL-1 in Cancer: From Tumor Progression to Resistance to Targeted Therapies, file e1dcb335-ba8f-7715-e053-1705fe0a6cc9 25
Expected and non-expected immune-related adverse events detectable by CT, file e1dcb338-a088-7715-e053-1705fe0a6cc9 19
The autocrine loop of ALK receptor and ALKAL2 ligand is an actionable target in consensus molecular subtype 1 colon cancer, file 04105a15-9cb3-4264-9f8b-06761ed18ce0 3
IL-1 Associated Post Senescence Reprogramming Impairs Response To EGFR Neutralization, file dabb68c4-e842-4c9f-92ef-9f8a92d8f721 1
Totale 789
Categoria #
all - tutte 2.316
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.316


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202041 0 0 0 3 7 4 6 4 5 5 4 3
2020/2021112 6 4 5 2 16 5 8 5 22 13 21 5
2021/2022183 5 16 12 29 19 8 7 8 11 10 42 16
2022/2023239 9 7 40 26 22 20 20 18 29 12 28 8
2023/2024214 14 22 8 17 14 48 17 21 30 23 0 0
Totale 789